We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why MOH Shares Are Attracting Prudent Investors Now
Read MoreHide Full Article
Key Takeaways
MOH saw two upward estimate revisions for 2025 earnings in the past 60 days, with none downward.
Premium revenues rose 11.8% in Q1 2025 and are projected to grow 9% YoY to $42B in 2025.
MOH secured a D-SNP contract in Illinois and expects 2025 membership to reach 5.9 million.
Molina Healthcare, Inc. (MOH - Free Report) is a multi-state managed care organization that provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. The company operates in three segments: Medicaid, Medicare and Marketplace. MOH stock has risen 1.5% in the year-to-date period against the industry’s average decline of 28.4%.
Headquartered in Long Beach, CA, MOH holds a market capitalization of $16 billion. The company offers health insurance plans sponsored by the government for individuals and families. It focuses on delivering affordable and comprehensive coverage, especially for lower-income people. Its trailing 12-month P/E ratio of 12.84X is higher than the industry average of 10.79X, indicating growing investor confidence.
Courtesy of solid prospects, MOH currently carries a Zacks Rank #2 (Buy).
Where Do Estimates for MOH Stand?
The Zacks Consensus Estimate for Molina Healthcare’s 2025 earnings is pegged at $24.44 per share, indicating a 7.9% year-over-year rise. In the past 60 days, it has witnessed two upward estimate revisions against none in the opposite direction. Furthermore, the consensus mark for revenues is pegged at $44.1 billion for 2025. It beat earnings estimates in three of the past four quarters and missed once.
Molina Healthcare continues to drive growth through strategic acquisitions. Premium revenues have experienced significant growth, driven by rate hikes, new Medicaid contract wins and expanding geographic footprints. In the first quarter of 2025, premium revenues rose 11.8% year over year to $10.6 billion. The company projects premium revenues to increase 9% year over year in 2025, which is likely to be around $42 billion.
As of March 31, 2025, total membership improved 0.4% year over year to around 5.8 million. The health insurer witnessed year-over-year increases in customers within its Medicare and Marketplace businesses. MOH expects total membership to be around 5.9 million in 2025, 7.3% higher than the 2024-end figure.
The company’s affordable health plans, which offer comprehensive benefits, have secured key contract wins. In 2025, Molina Healthcare was awarded a new contract to provide a Fully Integrated Dual Eligible Special Needs Plan (D-SNP) in Illinois through its subsidiary. This contract, awarded by the Illinois Department of Healthcare and Family Services, positions the company for strategic growth while enhancing its service offerings for dual-eligible beneficiaries.
MOH’s return on equity is 28.4%, better than the industry average of 24%. The metric reflects the company's effectiveness in utilizing its shareholders' money compared with its industry peers, which impresses investors. MOH's balance sheet strength provides financial flexibility. Its cash and cash equivalents of $4.9 billion at the first-quarter end were much higher than the long-term debt of $3.6 billion.
Risks
There are some factors, however, that investors should keep a careful eye on.
The company’s operating expenses have escalated over the last several years due to increasing medical care costs and general and administrative expenses. Total operating costs increased 5.5%, 19.8% and 12.7% year over year in 2023, 2024 and the first quarter of 2025, respectively. Higher expenses can put pressure on the company’s margins in the days ahead.
Molina Healthcare's medical care ratio (MCR) continues to be on the rise. A higher MCR indicates a lower proportion of remaining premiums after the payment of insurance claims. In the first quarter of 2025, the MCR deteriorated 70 basis points from the year-ago period.
The Zacks Consensus Estimate for Clover Health Investments’ current-year earnings of 11 cents per share has witnessed one upward revision in the past 60 days against no movement in the opposite direction. Clover Health Investments beat earnings estimates in each of the trailing four quarters, with the average surprise being 114.6%. The consensus estimate for current-year revenues is pegged at $1.9 billion, suggesting 37.7% year-over-year growth.
The Zacks Consensus Estimate for Encompass Health’s current-year earnings of $5.01 per share has witnessed eight upward revisions in the past 60 days against no movement in the opposite direction. Encompass Health beat earnings estimates in each of the trailing four quarters, with the average surprise being 12.3%. The consensus estimate for current-year revenues is pegged at $5.9 billion, suggesting 9.5% year-over-year growth.
The Zacks Consensus Estimate for Integer Holdings’ current-year earnings of $6.33 per share has witnessed five upward revisions in the past 60 days against no movement in the opposite direction. Integer Holdings beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 2.8%. The consensus estimate for current-year revenues is pegged at $1.9 billion, suggesting 7.7% year-over-year growth.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why MOH Shares Are Attracting Prudent Investors Now
Key Takeaways
Molina Healthcare, Inc. (MOH - Free Report) is a multi-state managed care organization that provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. The company operates in three segments: Medicaid, Medicare and Marketplace. MOH stock has risen 1.5% in the year-to-date period against the industry’s average decline of 28.4%.
Headquartered in Long Beach, CA, MOH holds a market capitalization of $16 billion. The company offers health insurance plans sponsored by the government for individuals and families. It focuses on delivering affordable and comprehensive coverage, especially for lower-income people. Its trailing 12-month P/E ratio of 12.84X is higher than the industry average of 10.79X, indicating growing investor confidence.
Courtesy of solid prospects, MOH currently carries a Zacks Rank #2 (Buy).
Where Do Estimates for MOH Stand?
The Zacks Consensus Estimate for Molina Healthcare’s 2025 earnings is pegged at $24.44 per share, indicating a 7.9% year-over-year rise. In the past 60 days, it has witnessed two upward estimate revisions against none in the opposite direction. Furthermore, the consensus mark for revenues is pegged at $44.1 billion for 2025. It beat earnings estimates in three of the past four quarters and missed once.
Molina Healthcare, Inc Price and EPS Surprise
Molina Healthcare, Inc price-eps-surprise | Molina Healthcare, Inc Quote
MOH’s Growth Drivers
Molina Healthcare continues to drive growth through strategic acquisitions. Premium revenues have experienced significant growth, driven by rate hikes, new Medicaid contract wins and expanding geographic footprints. In the first quarter of 2025, premium revenues rose 11.8% year over year to $10.6 billion. The company projects premium revenues to increase 9% year over year in 2025, which is likely to be around $42 billion.
As of March 31, 2025, total membership improved 0.4% year over year to around 5.8 million. The health insurer witnessed year-over-year increases in customers within its Medicare and Marketplace businesses. MOH expects total membership to be around 5.9 million in 2025, 7.3% higher than the 2024-end figure.
The company’s affordable health plans, which offer comprehensive benefits, have secured key contract wins. In 2025, Molina Healthcare was awarded a new contract to provide a Fully Integrated Dual Eligible Special Needs Plan (D-SNP) in Illinois through its subsidiary. This contract, awarded by the Illinois Department of Healthcare and Family Services, positions the company for strategic growth while enhancing its service offerings for dual-eligible beneficiaries.
MOH’s return on equity is 28.4%, better than the industry average of 24%. The metric reflects the company's effectiveness in utilizing its shareholders' money compared with its industry peers, which impresses investors. MOH's balance sheet strength provides financial flexibility. Its cash and cash equivalents of $4.9 billion at the first-quarter end were much higher than the long-term debt of $3.6 billion.
Risks
There are some factors, however, that investors should keep a careful eye on.
The company’s operating expenses have escalated over the last several years due to increasing medical care costs and general and administrative expenses. Total operating costs increased 5.5%, 19.8% and 12.7% year over year in 2023, 2024 and the first quarter of 2025, respectively. Higher expenses can put pressure on the company’s margins in the days ahead.
Molina Healthcare's medical care ratio (MCR) continues to be on the rise. A higher MCR indicates a lower proportion of remaining premiums after the payment of insurance claims. In the first quarter of 2025, the MCR deteriorated 70 basis points from the year-ago period.
Other Key Picks
Some other top-ranked stocks in the Medical space are Clover Health Investments Corp (CLOV - Free Report) , Encompass Health Corporation (EHC - Free Report) and Integer Holdings Corporation (ITGR - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Clover Health Investments’ current-year earnings of 11 cents per share has witnessed one upward revision in the past 60 days against no movement in the opposite direction. Clover Health Investments beat earnings estimates in each of the trailing four quarters, with the average surprise being 114.6%. The consensus estimate for current-year revenues is pegged at $1.9 billion, suggesting 37.7% year-over-year growth.
The Zacks Consensus Estimate for Encompass Health’s current-year earnings of $5.01 per share has witnessed eight upward revisions in the past 60 days against no movement in the opposite direction. Encompass Health beat earnings estimates in each of the trailing four quarters, with the average surprise being 12.3%. The consensus estimate for current-year revenues is pegged at $5.9 billion, suggesting 9.5% year-over-year growth.
The Zacks Consensus Estimate for Integer Holdings’ current-year earnings of $6.33 per share has witnessed five upward revisions in the past 60 days against no movement in the opposite direction. Integer Holdings beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 2.8%. The consensus estimate for current-year revenues is pegged at $1.9 billion, suggesting 7.7% year-over-year growth.